Acquisition under the Framework Agreement for the Supply of Cardiovascular System Medications - CP 2025/1627 - SPMS

This tender, identified by reference number 4526700266, is for the acquisition of medications for the cardiovascular system. The procurement is being conducted under an existing Framework Agreement (CP 2025/1627), managed by SPMS (Serviços Partilhados do Ministério da Saúde - Shared Services of the Ministry of Health). This indicates that the specific medications and terms of supply have likely been pre-negotiated and established within the framework agreement, simplifying the current acquisition process. The tender focuses on ensuring the continuous availability of essential drugs for treating cardiovascular conditions. Bidders are expected to be suppliers or distributors capable of providing these specified medications in compliance with the framework agreement's conditions. The objective is to secure a reliable supply chain for these critical pharmaceuticals, ensuring that healthcare providers have access to the necessary treatments for patients with heart and circulatory diseases. The tender process will likely involve confirming eligibility, adherence to the framework agreement's terms, and potentially specific delivery schedules or quantities required by the procuring entity. This initiative is crucial for maintaining the quality of care for patients with cardiovascular ailments.

This is a supplies contract in the health and medical services and general supplies sectors. Located in Portugal, Europe, this opportunity is open to firms and consortiums, with an estimated budget of EUR 419.

Published through base_gov_pt, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. This contract has already been awarded. The information is published for transparency and market intelligence purposes.